Abstract
ADP-ribosylation is a reversible and site-specific post-translational modification that regulates a wide array of cellular signaling pathways. Regulation of ADP-ribosylation is vital for maintaining genomic integrity, and uncontrolled accumulation of poly(ADP-ribosyl)ation triggers a poly(ADP-ribose) (PAR)–dependent release of apoptosis-inducing factor from mitochondria, leading to cell death. ADP-ribosyl-acceptor hydrolase 3 (ARH3) cleaves PAR and mono(ADP-ribosyl)ation at serine following DNA damage. ARH3 is also a metalloenzyme with strong metal selectivity. While coordination of two magnesium ions (MgA and MgB) significantly enhances its catalytic efficiency, calcium binding suppresses its function. However, how the coordination of different metal ions affects its catalysis has not been defined. Here, we report a new crystal structure of ARH3 complexed with its product ADP-ribose and calcium. This structure shows that calcium coordination significantly distorts the binuclear metal center of ARH3, which results in decreased binding affinity to ADP-ribose, and suboptimal substrate alignment, leading to impaired hydrolysis of PAR and mono(ADP-ribosyl)ated serines. Furthermore, combined structural and mutational analysis of the metal-coordinating acidic residues revealed that MgA is crucial for optimal substrate positioning for catalysis, whereas MgB plays a key role in substrate binding. Our collective data provide novel insights into the different roles of these metal ions and the basis of metal selectivity of ARH3 and contribute to understanding the dynamic regulation of cellular ADP-ribosylations during the DNA damage response.
Keywords: ARH3, PARP1, ADP-ribosylation, hydrolysis, metal specificity
Abbreviations: ADPR, ADP-ribose; ARH3, ADP-ribosyl-acceptor hydrolase 3; DBD, DNA-binding domain; HPF1, histone PARylation factor 1; ITC, isothermal titration calorimetry; MARylation, mono(ADP-ribosyl)ation; PAR, poly(ADP-ribose); PARG, PAR glycohydrolase; PARP, poly(ADP-ribose) polymerase; PARP1C, PARP1C catalytic domain; PARylation, poly(ADP-ribosyl)ation; PBST, PBS with Tween-20; PTM, post-translational modification
Rapid and effective responses to extracellular and intracellular signals are crucial for the maintenance of genomic integrity and determination of cell fate (1). Post-translational modifications (PTMs) of proteins through a site-specific addition of chemical groups, such as phosphorylation, acetylation, and ADP-ribosylation, enable cells to dynamically regulate diverse biological pathways in an appropriate and timely manner (2). Poly(ADP-ribosyl)ation (PARylation) is a reversible PTM, in which the negatively charged ADP-ribose (ADPR) units are transferred from NAD+ to specific residues of target proteins, such as glutamate, aspartate, serine, arginine, and lysine (3, 4, 5). Poly(ADP-ribose) (PAR) polymerases (PARPs), particularly PARP1/ADP-ribosyltransferase diphtheria toxin-like 1, catalyze PARylation, generating a long chain of linear or branched polymers (6). PARylation plays a pleiotropic role in normal physiology as well as pathological conditions, including regulation of DNA damage repair (7), chromatin structure (8) and transcription (9), RNA metabolism (10), and cell fate determination (11).
However, uncontrolled accumulation of cellular PARylation is cytotoxic, leading to cell death (12). In mammals, cellular PAR levels are dynamically regulated by two PAR turnover enzymes, ADP-ribosyl-acceptor hydrolase 3 (ARH3) and PAR glycohydrolase (PARG) (13, 14). This turnover of PARylation is not only required for effective control of cellular signaling pathways but also restores the cellular energy reservoir (15, 16). Although both ARH3 and PARG cleave the α(1″-2′) O-glycosidic linkages in PAR substrates (15), there is a substantial difference in their structure and mechanism. The macrodomain-containing PARG has both endoglycohydrolase and exoglycohydrolase activity, generating protein-free oligo(ADP-ribose) chains and mono-ADP-ribose, respectively (17, 18, 19). PARG is unable to cleave terminal mono(ADP-ribosyl)ations attached to target proteins (20).
In contrast, ARH3 has a unique ARH fold and a di-Mg2+-containing catalytic center (21, 22, 23) and can efficiently reverse not only PARylation but also mono(ADP-ribosyl)ation (MARylation) at serine; ARH3 can also cleave O-acetyl-ADPR and α-NAD+ in a Mg2+-dependent manner releasing free ADPR (24, 25, 26). Notably, it has been shown that serine ADP-ribosylation, which is specifically synthesized by PARP1/histone PARylation factor 1 (HPF1) and PARP2/histone PARylation factor 2 complexes, is the major cellular PTM following DNA damage (27, 28, 29). Therefore, ARH3 plays an essential role in the complete reversal of DNA damage–induced cellular ADP-ribosylation. Consistent with this model, ARH3−/− cells show enhanced accumulation of cellular PAR, leading to increased cell death following hydrogen peroxide–induced DNA damage (30). ARH3 deficiency has been linked to the development of a progressive neurodegeneration phenotype (31, 32).
We and others recently reported structures of full-length or truncated ARH3 bound to Mg2+ and ADPR, its reaction product (21, 22, 23). We identified a structurally flexible Glu flap that undergoes a dramatic “closed-to-open” conformational transition upon ADPR binding that supports the specificity of ARH3 for the 1″-O-linkage in substrates (22). The Glu flap appears to function as a gate control for substrate entrance. Consistent with this structural plasticity of ARH3, two Mg2+ ions (MgA and MgB) in the binuclear metal center exhibit different dynamics upon ligand binding (22), implying potentially different contributions of the two Mg2+ ions to ARH3 activity. Furthermore, it has been shown that Ca2+ significantly suppresses ARH3 activity, supporting the strong metal specificity of ARH3 (21, 22). However, despite the importance of metal coordination in ARH3 functions, the roles of each of the two Mg2+ ions and the basis of metal selectivity of ARH3 have not been defined.
Here, to address these previously unanswered questions on ARH3, we combined biochemical, biophysical, mutational, and structural tools. We found that Mg2+ coordination by ARH3 induces an approximately 60-fold increase in binding affinity to its product ADPR, whereas Ca2+ shows only a relatively moderate increase. Our new crystal structure of ARH3–ADPR–Ca2+ complex reveals that Ca2+ coordination significantly distorts the structure of the dimetallic catalytic center and interferes with optimal positioning of the 1″-OH group of the terminal ribose of ADPR, corresponding to the 1″-O-linkage in substrates, which results in impaired hydrolysis of PAR and serine mono(ADP-ribosyl)ated substrates. We further found that MgA and MgB play key but different roles for proper substrate alignment and substrate binding, respectively. Together, our results provide new insights into the metal-dependent mechanism and function of ARH3.
Results
Mg2+ coordination substantially enhances the ADPR-binding affinity of ARH3
A Mg2+-dependent catalytic mechanism and metal preference of ARH3 has been proposed by several groups (21, 22, 23, 33). In addition, it has been shown that Ca2+ effectively suppresses ARH3 functions, whereas Mn2+ shows minimal effects (21, 22). To gain insights into the basis for metal selectivity in ARH3, we used isothermal titration calorimetry (ITC) to determine the thermodynamic properties of ARH3 interactions with its reaction product ADPR in the absence (with EDTA) and the presence of Mg2+ and other divalent metals (Mn2+ and Ca2+) (Fig. 1, Table 1). The control injections into a buffer did not generate any significant heat (Fig. S1), indicating the signal comes from specific ADPR binding to ARH3. In all datasets, ARH3 binds to approximately one molecule of ADPR, which is consistent with reported crystal structures of ARH3–ADPR–Mg2+ complexes (21, 22, 23).
Table 1.
Proteins | Metals | KD (μM) | N (sites) | ΔG (kcal M−1) | ΔH (kcal M−1) | −TΔS (kcal M−1) |
---|---|---|---|---|---|---|
ARH3WT | EDTA | 80.65 ± 5.25 | 0.96 ± 0.08 | −5.59 | −5.164 | −0.42 |
Mg2+ | 1.42 ± 0.07 | 1.12 ± 0.01 | −7.98 | −9.29 | 1.31 | |
Mn2+ | 0.83 ± 0.05 | 1.09 ± 0.01 | −8.29 | −10.57 | 2.28 | |
Ca2+ | 7.81 ± 0.51 | 1.18 ± 0.01 | −6.96 | −5.71 | −1.25 | |
ARH3D77A | Mg2+ | 0.06 ± 0.01 | 1.18 ± 0.01 | −9.87 | −8.50 | −1.37 |
ARH3D314A | Mg2+ | 62.89 ± 2.90 | 0.96 ± 0.04 | −5.74 | −10.36 | 4.61 |
The addition of Mg2+ to ARH3 increases its binding affinity to ADPR nearly 60-fold, in comparison to that of the metal-free enzyme state (in the presence of EDTA), KDMg of 1.42 μM versus KDEDTA of 80.65 μM (Fig. 1, A and B, Table 1). The ADPR-binding affinity of ARH3 in the presence of Mn2+ is comparable to that with Mg2+ (KDMn of 0.83 μM), which is consistent with the similar level of PAR hydrolysis activity in the presence of Mg2+ or Mn2+ (Fig. 1C, Table 1) (22). In contrast, ARH3 showed a significantly lower ADPR-binding affinity in the presence of Ca2+ (KDCa of 7.81 μM), about a sixfold reduction in ADPR-binding affinity compared with that with Mg2+ (Fig. 1D, Table 1). Unlike Mg2+, the addition of Ca2+ resulted in less heat release (ΔH; −5.71 kcal M− [Ca2+] versus −9.29 kcal M− [Mg2+]) and an increase in entropy (TΔS) (Fig. 1, Table 1). The concentration of Ca2+ used for ITC (5 mM) is saturating, given that the Ca2+-dependent inhibitory was not further enhanced at higher Ca2+ concentrations (Fig. S2). Overall, the ADPR binding of ARH3 with inhibitory Ca2+ shows different isotherm and kinetic parameters from those with Mg2+ or Mn2+, which support enzymatic activity of ARH3, and shows features rather resembling those from metal-free ARH3 (in the presence of EDTA; Fig. 1A). Taken together, these results are consistent with the metal selectivity of ARH3 that enables its specific substrate recognition.
Ca2+ binding distorts the binuclear metal center of ARH3
We previously reported the ligand-driven conformational switch in ARH3 that enables specific recognition and cleavage of the 1″-O-linkage in substrates (22). Furthermore, we showed that even a subtle distortion in the active-site architecture can have a detrimental effect on ARH3 functions. Since Ca2+ significantly suppresses the enzymatic activity of ARH3 (21, 22) and the ADPR binding in the Ca2+-bound form of ARH3 resembles the metal-free state of ARH3 (Fig. 1), we reasoned that Ca2+ binding likely distorts the active-site arrangement and metal-coordinating geometry in ARH3. To test this model and dissect the structural basis for the inhibitory effect of Ca2+, we determined the structure of full-length ARH3 in complex with ADPR and Ca2+ at a resolution of 1.75 Å (Fig. 2A, Table S2). Two metal ions (CaA and CaB) and ADPR are positioned in a way similar to those found in the Mg2+-bound form (Fig. 2, B and D). However, the overall coordination geometry of the dimetallic catalytic center is remarkably different from that found in the Mg2+-bound form.
Unlike the Mg2+-bound form where both Mg2+ ions have a similar octahedral coordination geometry with six ligands, the coordination architecture of CaA and CaB shows a notable difference (Fig. 2, C and D, Table 2). CaB is coordinated with a total of seven ligands with an average metal–ligand distance of 2.49 Å (Fig. 2C, Table 2 and Table S1). This is slightly longer than that of MgB in the Mg2+-bound form (2.25 Å) and is likely because of the longer cationic diameter of calcium (radius of 0.99 Å) compared with magnesium (radius of 0.65 Å) (34). In contrast, CaA shows an octahedral but highly relaxed geometry. The average metal–ligand distance of CaA (2.82 Å) is substantially longer than that of MgA in the Mg2+-bound form (2.23 Å).
Table 2.
Metal | Distance (Å) | Coordinating atom | Distance (Å) | Coordinating atom | |
---|---|---|---|---|---|
CaA | 2.7 | Thr76-OG1 | MgA | 2.4 | Thr76-OG1 |
2.4 | Asp77-OD1 | 2.3 | Asp77-OD1 | ||
3.0 | Asp78-OD2 | 2.3 | Asp78-OD2 | ||
2.6 | Asp316-OD2 | 2.2 | Asp316-OD2 | ||
2.8 | W2-O | 2.2 | W2-O | ||
3.0 | ADPR (2″-OH) | 2.0 | μ-aqua-O | ||
CaB | 2.4 | Asp314-OD1 | MgB | 2.2 | As314-OD1 |
3.0 | Asp316-OD1 | 2.3 | Asp316-OD1 | ||
2.4 | Thr317-OG1 | 2.3 | Thr317-OG1 | ||
2.5 | W1-O | 2.1 | W1-O | ||
2.4 | ADPR (1″-OH) | 2.1 | μ-aqua (μ-W) | ||
2.6 | ADPR (2″-OH) | 2.5 | ADPR (3″-OH) | ||
2.4 | ADPR (3″-OH) |
In the ARH3–ADPR–Ca2+ complex, the orientation of 1″-OH group of the terminal ribose, corresponding to the 1″-O-linkage in uncleaved substrates, is tilted toward CaB (Fig. 2B). With respect to the Mg2+-bound form, the 1″-OH group is rotated ∼10° in the Ca2+-bound form. This rotation induces a concomitant ∼1 Å displacement of 1″-OH toward CaB. As a result, the 1″-OH group is directly coordinated to CaB, whereas 2″-OH bridges the dimetallic center by interacting with both Ca2+ ions (Fig. 2C).
Notably, the metal-bridging water (μ-aqua) is missing in the Ca2+-bound form (Fig. 2, C and D). In the Mg2+-bound form, this μ-aqua ligand simultaneously engages both Mg2+ ions and the 2″-OH. This μ-aqua ligand is missing in three of four ARH3–ADPR–Ca2+ complexes in the asymmetric unit, and only a very weak electron density was found in the last ARH3 molecule. Instead, two Ca2+ ions are bridged by 2″-OH of the terminal ribose (Fig. 2C), which causes the tilted confirmation of the terminal ribose. This absence of the bridging water ligand may explain the shorter metal–metal distance in the Ca2+-bound form than in the Mg2+-bound form (3.1 Å [Ca2+–Ca2+] versus 3.3 Å [Mg2+–Mg2+]) (Table S1).
Taken together, our findings suggest that the distorted di-Ca2+ metal center and the tilted conformation of 1″-OH, a position for the scissile O-linkage in substrates, are likely to interfere with a precise alignment of substrates for nucleophilic attack, resulting in suppression of enzymatic activities of ARH3. These results also support the hypothesis that a subtle change in the metal-coordination arrangement can result in a detrimental effect on ARH3 functions.
Metal-coordinating acidic residues are critical for the catalytic activity of ARH3
To gain further insights into the structure–function relationship of the dimetallic catalytic center and its metal-coordination geometry, we substituted acidic residues that directly coordinate metals (Asp77, Asp78, Asp314, and Asp316) with alanine. Asp77 and Asp314 interact with both ADPR and Mg2+, whereas Asp78 and Asp316 coordinate only MgA and MgB, respectively but do not directly interact with ADPR. We purified these mutants (Fig. 3D) and monitored their PAR and serine MARylation hydrolytic activities in the presence of Mg2+, EDTA, and Ca2+ (Fig. 3).
The addition of a metal-chelating EDTA or Ca2+ effectively suppresses PAR hydrolysis by ARH3, which is in good agreement with published results (Fig. 3A) (21, 22). Among ARH3 mutants, only ARH3D314A showed some residual PAR hydrolysis activity in the presence of Mg2+, and the others were nearly inactive in all three tested metal conditions (Fig. 3A).
While the WT enzyme efficiently reversed the serine-linked MARylated PARP1 substrate, all tested ARH3 mutants lacked enzymatic activity (Fig. 3, B and C). Collectively, these results suggest that metal-coordinating residues in the active site of ARH3 are critical for both PAR and MAR hydrolysis, and de-MARylation function of ARH3 appears to require a more strict structural integrity to specifically recognize and/or cleave MARylated substrates.
MgA is required for precise substrate alignment, whereas MgB is important for substrate binding
In WT ARH3, Asp77 not only interacts with 2″-OH of the terminal ribose but also coordinates MgA. Thus, Asp77 appears to be important for the maintenance of integrity of MgA and the optimal orientation of the terminal ribose for catalysis. Similarly, on the other side of the active site, Asp314 interacts with 3″-OH of the terminal ribose and MgB. Asp314 seems to contribute to the integrity of MgB, given that the substitution of Asp314 with glutamate eliminates MgB from the active site (22). To gain further structural basis for different alterations in enzymatic activity in D77A and D314A mutants and to better understand the roles of each Mg2+ ion in ARH3, we determined the high-resolution crystal structures of ARH3D77A and ARH3D314A bound to ADPR and Mg2+ at a resolution of 1.85 and 1.80 Å, respectively.
Structural analysis of ARH3D77A reveals that MgA is missing (Fig. 4, A and B). This lack of MgA causes a large-scale rearrangement in the active site. First, the terminal ribose is rotated ∼37° using MgB as a pivot (Fig. 4B). Because of this rotation, which is an even greater degree of rotation than that found in the Ca2+-bound form of ARH3 (Fig. 2), the 2″-OH group replaces the metal-bridging μ-aqua ligand and directly interacts with MgB. In this conformation, the 2″-OH group makes additional hydrogen bonds with side chains of Asp78 and Asp316, and the 1″-OH group makes a new hydrogen bond with the main carbonyl chain of Gly115 (Fig. 4C and Fig. S2). Consistently, ARH3D77A shows a 23-fold increase in ADPR-binding affinity, compared with ARH3WT (Fig. 5A, Table 1). As a result, the 1″-OH group is displaced ∼2.4 Å toward Ala77 (Fig. 4B). This significantly rotated conformation of ADPR in ARH3D77A, with respect to ARH3WT, is likely to interfere with a correct substrate positioning for catalysis (Fig. 4B). Together, the coordination of MgA appears to contribute to the optimal alignment of substrate, while it sacrifices the overall substrate-binding affinity of ARH3.
In the structure of ARH3D314A, similar to ARH3D314E (22), MgB is missing (Fig. 4D). Unlike ARH3D77A, the orientation of ADPR in ARH3D314A is nearly identical to that in ARH3WT, and critical residues for the formation of the binuclear metal center occupy nearly identical positions (Fig. 4E). This finding is in line with the proposed important role of MgA for precise substrate alignment. The geometry of MgA is also maintained in an octahedral shape as seen in ARH3WT (Fig. 4F). Overall, in contrast to ARH3D77A, ARH3D314A appears to show a limited effect on the alignment of the terminal ribose (Fig. 4F and Fig. S2). Rather, MgB appears to be important for substrate binding. The 3″-OH group of the terminal ribose, which is originally in direct coordination with MgB and the side chain of Asp314 (Fig. S3), lacks interactions with the enzyme in the structure of ARH3D314A and is disordered (Fig. 4F). Consistent with these findings, ARH3D314A shows a 44-fold decrease in ADPR-binding affinity compared with ARH3WT (Fig. 5B, Table 1). Notably, this reduced ADPR-binding affinity mimics the metal-free state of ARH3 (Fig. 1, Table 1), further supporting the hypothesis that MgB is critical for substrate binding in ARH3.
Taken together, these findings imply that MgA is important for the optimal positioning of substrates, whereas MgB plays a key role for substrate binding in ARH3.
Discussion
Our combined structural, biochemical, and mutational analysis reveal new insights into the metal selectivity and different roles of two metal ions in ARH3. Our new crystal structure of the ARH3–ADPR–Ca2+ complex explains the strong preference of Mg2+ over Ca2+ and the Ca2+-mediated inhibition of ADP-ribosyl-acceptor hydrolase activities of ARH3. Although overall folding of ARH3 remains nearly identical upon substitution of Mg2+ with Ca2+ (Fig. 2B), our careful structural analysis showed that Ca2+ coordination in ARH3 results in significant rearrangements in geometry, coordination, and metal–ligand distances of the binuclear metal center, explaining the impaired ARH3 activities in the presence of Ca2+ (Fig. 3).
In contrast to Mg2+ (Fig. 2D, Table 2), Ca2+ ions can coordinate up to eight metal ligands (35, 36). In our structure, CaB is coordinated with seven ligands, including the 1″-OH (scissile O-linkage in substrates) and 2″-OH, and CaA shows a very relaxed octahedral geometry (Fig. 2C). The significantly distorted active-site structure and reduced binding affinity in the Ca2+-bound form of ARH3 are consistent with the proposed roles of MgA and MgB in substrate alignment and binding. For example, the highly relaxed CaA geometry, compared with the Mg2+-bound form, likely interferes with an optimal substrate alignment in ARH3 and following nucleophilic attack on the distal ribose. In addition, Ca2+ ions can reduce the chemical reactivity of metal-bound water molecules. Previous studies reported that a Ca2+-bound water molecule has a higher pKa (12.9) in comparison to that bound to Mg2+ (11.4) or Mn2+ (10.9) (34). Consequently, a nucleophilic attack on substrates becomes less favorable (37). Finally, it is possible that the larger size of Ca2+ (radius of 0.99 Å) (34), compared with Mg2+ (radius of 0.65 Å) and Mn2+ (radius of 0.80 Å), along with its preference for a higher coordination number (up to eight ligands), might cause steric interference with the coordinated oxygen atoms, possibly perturbing the stability of the transition state.
Our atomic-resolution structures and mutational analysis define the different roles of two Mg2+ ions in ARH3. Although several mutations were previously reported (38), our results provide extended and atomic resolution insights into the roles of key acidic residues in the binuclear catalytic center. Furthermore, we compared effects of mutations both on serine MARylated substrates and PARylated substrates. In the active site of ARH3, acidic residues, including Asp77, Asp78, Asp314, and Asp316, maintain the integrity of the bimetallic center and render the ideal alignment of the substrate for catalysis (22). These metal-coordinating acidic residues are critical for hydrolysis of PAR and ADPR–serine (Fig. 3). In the ARH3D77A structure, in which MgA is missing, the terminal ribose of ADPR is rotated ∼37°, which is approximately four times greater than the rotation found in the Ca2+-bound form (Figs. 2 and 4). This distorted conformation, together with a surprisingly increased binding affinity to ADPR in ARH3D77A (Table 1), would presumably interfere with correct substrate positioning for catalysis (Fig. 4B). Given the missing MgA, a complete loss of enzymatic activity, and an increased ADPR-binding affinity in ARH3D77A (Fig. 3A), MgA appears to play an important role in catalysis by sacrificing the substrate-binding affinity. Also, these findings raise the possibility that Asp77 may function as a catalytic residue. In contrast, ARH3D314A, in which MgB is missing, shows nearly identical active-site structure, but an impaired ADPR-binding affinity, which is comparable to the metal-free ARH3 (Table 1). The limited alteration in the ADPR-binding mode in the absence of MgB further supports the conclusion that MgA is crucial for substrate alignment. Taken together, we propose that the coordination of MgA appears to contribute to the optimal alignment of substrate, whereas MgB is crucial for substrate binding.
Among the ARH–macrodomain family of ADP-ribosylation reversal enzymes, ARH3 is a unique multitasking metalloenzyme that regulates cellular concentrations of multiple ADP-ribosylated substrates, including PAR (Fig. 3A), serine MAR (Fig. 3B), O-acetyl-ADPR (26, 39), and α-NAD+ (25). These ADP-ribosylated substrates play key roles in cellular signaling pathways, such as the DNA damage response and determination of cell death. Although more work needs to be done to define the comprehensive metal-dependent catalytic mechanism in ARH3, the structural and biochemical data presented here provide detailed insights into the dynamic active-site rearrangement upon coordination of different divalent metals and suggest specific and different roles of MgA and MgB. The observed metal preference of ARH3 to Mg2+ supports the structural plasticity and broad substrate specificity of ARH3, while maintaining the structural integrity of the active site. Finally, our data suggest that the change in cellular concentrations of divalent metals, such as Ca2+, can modulate ARH3 functions.
Experimental procedures
Plasmids and protein purification
WT ARH3 (ARH3WT), the DNA-binding domain (DBD; residues 1–374), and the PARP1C catalytic domain (PARP1C; residues 375–1014) of human PARP1 were purified as described previously (22). To purify biotinylated PARP1C, the corresponding gene was cloned into a pET28a vector with a C-terminal biotin affinity peptide tag for biotinylation and an N-terminal His6 tag for purification. PARP1C was coexpressed in Escherichia coli BL21 cells expressing the biotin ligase BirA that biotinylates the biotin affinity peptide tag on its lysine residue. Genes for mutants of ARH3 were synthesized and cloned into a modified pET21b vector with an N-terminal His6 tag and a following cleavage site for PreScission protease (pET21b-His6-pps) by Gene Universal Inc. All plasmids were sequenced, and mutations were confirmed. The biotinylated PARP1C and ARH3 mutant proteins were purified using the same protocol as ARH3WT. A gene for human HPF1 was synthesized and cloned into the pET21b-His6-pps by Gene Universal Inc. HPF1 was purified as described previously (29).
ITC
ITC experiments were performed at 25 °C in a buffer containing 150 mM NaCl, 100 mM Tris at pH 7.5, and 5 mM divalent metals (MgCl2, MnCl2, and CaCl2) or EDTA (Sigma–Aldrich). The WT or mutants of ARH3 were placed in a cell at 50 μM concentration, and ADPR was placed in the injection syringe at 660 μM concentration. Overall, 26 injections (10 μl per injection except for the first sample [5 μl]) were administered with an interval of 5 min between peaks to allow the baseline to be stabilized. Control experiments were conducted under the same condition to determine the heat of dilution by injecting ADPR to buffers, which shows no significant heat generation (Fig. S1). The obtained plots were fitted with a single-site binding model in the Origin software package (MicroCal, Inc).
PAR turnover assay
A gel-based PAR-turnover assay was performed to evaluate the enzymatic activity of ARH3WT, ARH3D77A, ARH3D78A, ARH3D314A, and ARH3D316A, as described previously (14, 40). Briefly, 2 μM of the catalytic domain of human PARP1 (PARP1C; residues 375–1014) was auto-PARylated at 37 °C for 30 min in the presence of 2 μM DBD of PARP1 (residues 1–374), 2 μM double-stranded DNA, and 400 μM β-NAD+ (Sigma) in a buffer containing 100 mM NaCl, 50 mM Tris (pH 7.5), 10 mM MgCl2, and 2 mM DTT. ARH3 proteins (in the presence of 5 mM EDTA, Mg2+, or Ca2+) with final concentrations of 2 μM were mixed with the PARylated PARP1C substrate, followed by incubation for 1 h in 37 °C. Reactions then were stopped by adding 4× SDS-loading dye (Bio-Rad) and visualized by Coomassie blue staining of SDS-polyacrylamide gels.
Serine mono(ADP-ribosyl)ation turnover assay
To generate serine-linked MARylated substrate, 4 μM of PARP1C was first PARylated in the presence of 4 μM PARP1 DBD, 8 μM HPF1, 2 μM double-stranded DNA, and 400 μM β-NAD+ (Sigma–Aldrich) in a buffer containing 100 mM NaCl, 50 mM Tris (pH 7.5), 10 mM MgCl2, and 2 mM DTT. The reaction then was passed through a PD-10 column to remove excess β-NAD+. PARP inhibitor, Olaparib (SelleckChem), at 8 μM was then added before performing dePARylation of the substrate by incubating with 10 nM PARG for 30 min in 37 °C. The generated serine-linked MARylated PARP1C was passed through a PD-10 column to remove protein-free PAR and ADPR units, followed by aliquoting and storing in −80 °C. ARH3 proteins at a final concentration of 60 nM were treated into the serine-MARylated substrate in a buffer containing 50 mM Tris–HCl (pH 7.5), 50 mM NaCl, and 5 mM MgCl2, followed by incubation for 1 h in 37 °C. Reactions then were stopped by adding 4× SDS-loading dye and resolved by 10% SDS-polyacrylamide gels.
Western blotting
To visualize and quantify the level of serine-MARylation, we performed Western blotting on samples. Reactions were transferred to polyvinylidene fluoride membranes. Polyvinylidene fluoride membranes first were blocked by incubation in PBS with Tween-20 (PBST) buffer containing 5% nonfat skim milk for 1 h at room temperature. After one washing step with PBST, membranes were incubated with anti–pan-ADPR antibody (Sigma–Aldrich; 3 μg/ml final concentration), anti-ARH3 N-terminal antibody (Aviva System Biology) (1/1000 dilution), and antibiotin antibody (Invitrogen; 0.25 μg/ml final concentration) overnight at 4 °C. After three steps of wash with PBST, blots were incubated with horseradish peroxidase–conjugated polyclonal secondary anti-rabbit antibody (Thermo Fisher; 1/10,000 dilution) for 1 h at room temperature. Afterward, membranes were washed three times with PBST and finally visualized by enhanced chemiluminescence detection kit using the iBRIGHT-FL1000 imager (Thermo Fisher). Bands were quantified using ImageJ software (National Institutes of Health).
Crystallization and data collection
The ARH3WT, ARH3D77A, and ARH3D314A (10 mg/ml) were cocrystallized with 5 mM ADPR (Sigma–Aldrich) and 5 mM Ca2+ (for ARH3WT) or Mg2+ (for ARH3D77A and ARH3D314A) by hanging-drop vapor diffusion (22). Briefly, 1 μl of protein samples was mixed with 1 μl mother liquor containing 0.1 M sodium acetate buffer (pH 4.5), 0.1 M MgCl2 or CaCl2, and 20 to 24% PEG 4000. About 24-well plates were placed in 22 °C incubator until crystals appeared. Harvested crystals were transferred into a cryoprotectant solution (26% PEG 4000; 0.1 M sodium acetate; pH 4.5; 0.1 M corresponding divalent metal; 5 mM ADPR; and 10% glycerol) before flash cooling in liquid nitrogen for data collection.
X-ray diffraction data were collected at the NE-CAT 24ID-E beamline at the Advanced Photon Source. The ARH3WT–ADPR–Ca2+ complex crystals (P1; four ARH3–ADPR–Ca2+ complexes per asymmetric unit) diffracted to a resolution of 1.75 Å, ARH3D77A–ADPR–Mg2+ complex crystals (P1) diffracted to a resolution of 1.85 Å, and ARH3D314A–ADPR–Mg2+ complex crystals (P1) diffracted to a resolution of 1.80 Å. X-ray datasets were collected with an Eiger 16M detector (Dectris) and processed using HKL2000 (41) and SCALEPACK (HKL Research, Inc.) (41, 42). Data collection statistics are shown in Table S2.
Structure determination
Structures were determined by molecular replacement using MOLREP (43, 44) in the CCP4 suite (44) with the ARH3WT–ADPR–Mg2+ structure (Protein Data Bank ID: 6D36) as a search model. Models were manually built using Coot (45) and refined in PHENIX (46); Rfactor of 14.9% and Rfree of 18.8% for ARH3WT–ADPR–Ca2+, Rfactor of 18.1% and Rfree of 22.7% for ARH3D77A–ADPR–Mg2+, and Rfactor of 18.8% and Rfree of 22.7% for ARH3D314A–ADPR–Mg2+. Crystallographic data are shown in Table S2. Ramachandran plots indicate that >98% of residues in all three structures are in favored regions, and all others are in allowed regions. No outlier residue is observed.
Data availability
Atomic coordinates and structure factors of the ARH3WT–ADPR–Ca2+, ARH3D77A–ADPR–Mg2+, and ARH3D314A–ADPR–Mg2+ complexes have been deposited in the Protein Data Bank under accession numbers 7L9F, 7L9H, and 7L9I, respectively.
Supporting information
This article contains supporting information (22).
Conflict of interest
The authors declare that they have no conflicts of interest with the contents of this article.
Acknowledgments
This work used Northeastern Collaborative Access Team beamlines (P30 GM124165) and an Eiger 16M detector on 24-ID-E beamline (S10OD021527) at the Advanced Photon Source (DE-AC02-06CH11357).
Author contributions
Y. P. and Z. M. designed experiments and ran ARH3 assays. Y. P. crystallized proteins and determined and analyzed structures. I. K. collected and processed X-ray datasets. Y. P., Z. M., J. M., and I. -K. K. analyzed data and wrote the article. I. -K. K. supervised overall studies.
Funding and additional information
I. -K. K. was supported by National Institutes of Health (United States) (R01 GM141226 to I. -K. K.) American Cancer Society Research Scholar Grant (133405-RSG-19-200-01-DMC to I. -K. K.), V Foundation V Scholar Grant (V2018-25 to I. -K. K.), and Marlene Harris Ride Cincinnati Breast Cancer Pilot Grant program (to I. -K. K.). J. M. was supported by the Intramural Research Program, National Institutes of Health and National Heart, Lung, and Blood Institute (United States). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Edited by Patrick Sung
Supporting information
References
- 1.Palazzo L., Mikoč A., Ahel I. ADP-ribosylation: New facets of an ancient modification. FEBS J. 2017;284:2932–2946. doi: 10.1111/febs.14078. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.O'Sullivan J., Tedim Ferreira M., Gagne J.P., Sharma A.K., Hendzel M.J., Masson J.Y., Poirier G.G. Emerging roles of eraser enzymes in the dynamic control of protein ADP-ribosylation. Nat. Commun. 2019;10:1182. doi: 10.1038/s41467-019-08859-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Gupte R., Liu Z., Kraus W.L. PARPs and ADP-ribosylation: Recent advances linking molecular functions to biological outcomes. Genes Dev. 2017;31:101–126. doi: 10.1101/gad.291518.116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Langelier M.F., Eisemann T., Riccio A.A., Pascal J.M. PARP family enzymes: Regulation and catalysis of the poly(ADP-ribose) posttranslational modification. Curr. Opin. Struct. Biol. 2018;53:187–198. doi: 10.1016/j.sbi.2018.11.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Pascal J.M., Ellenberger T. The rise and fall of poly(ADP-ribose): An enzymatic perspective. DNA Repair (Amst.) 2015;32:10–16. doi: 10.1016/j.dnarep.2015.04.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Luo X., Kraus W.L. On PAR with PARP: Cellular stress signaling through poly(ADP-ribose) and PARP-1. Genes Dev. 2012;26:417–432. doi: 10.1101/gad.183509.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Ray Chaudhuri A., Nussenzweig A. The multifaceted roles of PARP1 in DNA repair and chromatin remodelling. Nat. Rev. Mol. Cell Biol. 2017;18:610–621. doi: 10.1038/nrm.2017.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Beneke S. Regulation of chromatin structure by poly(ADP-ribosyl)ation. Front. Genet. 2012;3:169. doi: 10.3389/fgene.2012.00169. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Kraus W.L., Hottiger M.O. PARP-1 and gene regulation: Progress and puzzles. Mol. Aspects Med. 2013;34:1109–1123. doi: 10.1016/j.mam.2013.01.005. [DOI] [PubMed] [Google Scholar]
- 10.Bock F.J., Todorova T.T., Chang P. RNA regulation by poly(ADP-ribose) polymerases. Mol. Cell. 2015;58:959–969. doi: 10.1016/j.molcel.2015.01.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Vyas S., Chesarone-Cataldo M., Todorova T., Huang Y.H., Chang P. A systematic analysis of the PARP protein family identifies new functions critical for cell physiology. Nat. Commun. 2013;4:2240. doi: 10.1038/ncomms3240. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Andrabi S.A., Kim N.S., Yu S.W., Wang H., Koh D.W., Sasaki M., Klaus J.A., Otsuka T., Zhang Z., Koehler R.C., Hurn P.D., Poirier G.G., Dawson V.L., Dawson T.M. Poly(ADP-ribose) (PAR) polymer is a death signal. Proc. Natl. Acad. Sci. U. S. A. 2006;103:18308–18313. doi: 10.1073/pnas.0606526103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Mashimo M., Moss J. ADP-ribosyl-acceptor hydrolase activities catalyzed by the ARH family of proteins. Methods Mol. Biol. 2018;1813:187–204. doi: 10.1007/978-1-4939-8588-3_12. [DOI] [PubMed] [Google Scholar]
- 14.Kim I.K., Kiefer J.R., Ho C.M., Stegeman R.A., Classen S., Tainer J.A., Ellenberger T. Structure of mammalian poly(ADP-ribose) glycohydrolase reveals a flexible tyrosine clasp as a substrate-binding element. Nat. Struct. Mol. Biol. 2012;19:653–656. doi: 10.1038/nsmb.2305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Barkauskaite E., Jankevicius G., Ahel I. Structures and mechanisms of enzymes employed in the synthesis and degradation of PARP-dependent protein ADP-ribosylation. Mol. Cell. 2015;58:935–946. doi: 10.1016/j.molcel.2015.05.007. [DOI] [PubMed] [Google Scholar]
- 16.Hassa P.O., Haenni S.S., Elser M., Hottiger M.O. Nuclear ADP-ribosylation reactions in mammalian cells: Where are we today and where are we going? Microbiol. Mol. Biol. Rev. 2006;70:789–829. doi: 10.1128/MMBR.00040-05. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Brochu G., Duchaine C., Thibeault L., Lagueux J., Shah G.M., Poirier G.G. Mode of action of poly(ADP-ribose) glycohydrolase. Biochim. Biophys. Acta. 1994;1219:342–350. doi: 10.1016/0167-4781(94)90058-2. [DOI] [PubMed] [Google Scholar]
- 18.Barkauskaite E., Brassington A., Tan E.S., Warwicker J., Dunstan M.S., Banos B., Lafite P., Ahel M., Mitchison T.J., Ahel I., Leys D. Visualization of poly(ADP-ribose) bound to PARG reveals inherent balance between exo- and endo-glycohydrolase activities. Nat. Commun. 2013;4:2164. doi: 10.1038/ncomms3164. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Pourfarjam Y., Kasson S., Tran L., Ho C., Lim S., Kim I.K. PARG has a robust endo-glycohydrolase activity that releases protein-free poly(ADP-ribose) chains. Biochem. Biophys. Res. Commun. 2020;527:818–823. doi: 10.1016/j.bbrc.2020.04.120. [DOI] [PubMed] [Google Scholar]
- 20.Slade D., Dunstan M.S., Barkauskaite E., Weston R., Lafite P., Dixon N., Ahel M., Leys D., Ahel I. The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase. Nature. 2011;477:616–620. doi: 10.1038/nature10404. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Rack J.G.M., Ariza A., Drown B.S., Henfrey C., Bartlett E., Shirai T., Hergenrother P.J., Ahel I. (ADP-ribosyl)hydrolases: Structural basis for differential substrate recognition and inhibition. Cell Chem. Biol. 2018;25:1533–1546.e1512. doi: 10.1016/j.chembiol.2018.11.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Pourfarjam Y., Ventura J., Kurinov I., Cho A., Moss J., Kim I.K. Structure of human ADP-ribosyl-acceptor hydrolase 3 bound to ADP-ribose reveals a conformational switch that enables specific substrate recognition. J. Biol. Chem. 2018;293:12350–12359. doi: 10.1074/jbc.RA118.003586. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Wang M., Yuan Z., Xie R., Ma Y., Liu X., Yu X. Structure-function analyses reveal the mechanism of the ARH3-dependent hydrolysis of ADP-ribosylation. J. Biol. Chem. 2018;293:14470–14480. doi: 10.1074/jbc.RA118.004284. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Abplanalp J., Leutert M., Frugier E., Nowak K., Feurer R., Kato J., Kistemaker H.V.A., Filippov D.V., Moss J., Caflisch A., Hottiger M.O. Proteomic analyses identify ARH3 as a serine mono-ADP-ribosylhydrolase. Nat. Commun. 2017;8:2055. doi: 10.1038/s41467-017-02253-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Stevens L.A., Kato J., Kasamatsu A., Oda H., Lee D.Y., Moss J. The ARH and macrodomain families of alpha-ADP-ribose-acceptor hydrolases catalyze alpha-NAD(+) hydrolysis. ACS Chem. Biol. 2019;14:2576–2584. doi: 10.1021/acschembio.9b00429. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Kasamatsu A., Nakao M., Smith B.C., Comstock L.R., Ono T., Kato J., Denu J.M., Moss J. Hydrolysis of O-acetyl-ADP-ribose isomers by ADP-ribosylhydrolase 3. J. Biol. Chem. 2011;286:21110–21117. doi: 10.1074/jbc.M111.237636. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Palazzo L., Leidecker O., Prokhorova E., Dauben H., Matic I., Ahel I. Serine is the major residue for ADP-ribosylation upon DNA damage. Elife. 2018;7 doi: 10.7554/eLife.34334. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Bonfiglio J.J., Fontana P., Zhang Q., Colby T., Gibbs-Seymour I., Atanassov I., Bartlett E., Zaja R., Ahel I., Matic I. Serine ADP-ribosylation depends on HPF1. Mol. Cell. 2017;65:932–940.e936. doi: 10.1016/j.molcel.2017.01.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Suskiewicz M.J., Zobel F., Ogden T.E.H., Fontana P., Ariza A., Yang J.C., Zhu K., Bracken L., Hawthorne W.J., Ahel D., Neuhaus D., Ahel I. HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation. Nature. 2020;579:598–602. doi: 10.1038/s41586-020-2013-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Mashimo M., Kato J., Moss J. ADP-ribosyl-acceptor hydrolase 3 regulates poly (ADP-ribose) degradation and cell death during oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 2013;110:18964–18969. doi: 10.1073/pnas.1312783110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Danhauser K., Alhaddad B., Makowski C., Piekutowska-Abramczuk D., Syrbe S., Gomez-Ospina N., Manning M.A., Kostera-Pruszczyk A., Krahn-Peper C., Berutti R., Kovacs-Nagy R., Gusic M., Graf E., Laugwitz L., Roblitz M. Bi-allelic ADPRHL2 mutations cause neurodegeneration with developmental delay, ataxia, and axonal neuropathy. Am. J. Hum. Genet. 2018;103:817–825. doi: 10.1016/j.ajhg.2018.10.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Mashimo M., Bu X., Aoyama K., Kato J., Ishiwata-Endo H., Stevens L.A., Kasamatsu A., Wolfe L.A., Toro C., Adams D., Markello T., Gahl W.A., Moss J. PARP1 inhibition alleviates injury in ARH3-deficient mice and human cells. JCI Insight. 2019;4 doi: 10.1172/jci.insight.124519. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Oka S., Kato J., Moss J. Identification and characterization of a mammalian 39-kDa poly(ADP-ribose) glycohydrolase. J. Biol. Chem. 2006;281:705–713. doi: 10.1074/jbc.M510290200. [DOI] [PubMed] [Google Scholar]
- 34.Glusker J.P. Structural aspects of metal liganding to functional groups in proteins. Adv. Protein Chem. 1991;42:1–76. doi: 10.1016/s0065-3233(08)60534-3. [DOI] [PubMed] [Google Scholar]
- 35.Falke J.J., Drake S.K., Hazard A.L., Peersen O.B. Molecular tuning of ion binding to calcium signaling proteins. Q. Rev. Biophys. 1994;27:219–290. doi: 10.1017/s0033583500003012. [DOI] [PubMed] [Google Scholar]
- 36.Grosshans C.A., Cech T.R. Metal ion requirements for sequence-specific endoribonuclease activity of the tetrahymena ribozyme. Biochemistry. 1989;28:6888–6894. doi: 10.1021/bi00443a017. [DOI] [PubMed] [Google Scholar]
- 37.Mordasini T., Curioni A., Andreoni W. Why do divalent metal ions either promote or inhibit enzymatic reactions? The case of BamHI restriction endonuclease from combined quantum-classical simulations. J. Biol. Chem. 2003;278:4381–4384. doi: 10.1074/jbc.C200664200. [DOI] [PubMed] [Google Scholar]
- 38.Mueller-Dieckmann C., Kernstock S., Lisurek M., von Kries J.P., Haag F., Weiss M.S., Koch-Nolte F. The structure of human ADP-ribosylhydrolase 3 (ARH3) provides insights into the reversibility of protein ADP-ribosylation. Proc. Natl. Acad. Sci. U. S. A. 2006;103:15026–15031. doi: 10.1073/pnas.0606762103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Ono T., Kasamatsu A., Oka S., Moss J. The 39-kDa poly(ADP-ribose) glycohydrolase ARH3 hydrolyzes O-acetyl-ADP-ribose, a product of the Sir2 family of acetyl-histone deacetylases. Proc. Natl. Acad. Sci. U. S. A. 2006;103:16687–16691. doi: 10.1073/pnas.0607911103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Kim I.K., Stegeman R.A., Brosey C.A., Ellenberger T. A quantitative assay reveals ligand specificity of the DNA scaffold repair protein XRCC1 and efficient disassembly of complexes of XRCC1 and the poly(ADP-ribose) polymerase 1 by poly(ADP-ribose) glycohydrolase. J. Biol. Chem. 2015;290:3775–3783. doi: 10.1074/jbc.M114.624718. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1997;276:307–326. doi: 10.1016/S0076-6879(97)76066-X. [DOI] [PubMed] [Google Scholar]
- 42.Pflugrath J.W. The finer things in X-ray diffraction data collection. Acta Crystallogr. D Biol. Crystallogr. 1999;55:1718–1725. doi: 10.1107/s090744499900935x. [DOI] [PubMed] [Google Scholar]
- 43.Vagin A., Teplyakov A. Molecular replacement with MOLREP. Acta Crystallogr. D Biol. Crystallogr. 2010;66:22–25. doi: 10.1107/S0907444909042589. [DOI] [PubMed] [Google Scholar]
- 44.Winn M.D., Ballard C.C., Cowtan K.D., Dodson E.J., Emsley P., Evans P.R., Keegan R.M., Krissinel E.B., Leslie A.G., McCoy A., McNicholas S.J., Murshudov G.N., Pannu N.S., Potterton E.A., Powell H.R. Overview of the CCP4 suite and current developments. Acta Crystallogr. D Biol. Crystallogr. 2011;67:235–242. doi: 10.1107/S0907444910045749. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Emsley P., Cowtan K. Coot: Model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 2004;60:2126–2132. doi: 10.1107/S0907444904019158. [DOI] [PubMed] [Google Scholar]
- 46.Afonine P.V., Grosse-Kunstleve R.W., Echols N., Headd J.J., Moriarty N.W., Mustyakimov M., Terwilliger T.C., Urzhumtsev A., Zwart P.H., Adams P.D. Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr. D Biol. Crystallogr. 2012;68:352–367. doi: 10.1107/S0907444912001308. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Atomic coordinates and structure factors of the ARH3WT–ADPR–Ca2+, ARH3D77A–ADPR–Mg2+, and ARH3D314A–ADPR–Mg2+ complexes have been deposited in the Protein Data Bank under accession numbers 7L9F, 7L9H, and 7L9I, respectively.